SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Cashflow Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-3.38 Cr | ₹4.74 Cr | ₹-0.64 Cr |
What is the latest Net Cash Inflow / Outflow ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹-3.38 Cr |
| Mar2024 | ₹4.74 Cr |
| Mar2023 | ₹-0.64 Cr |
How is Net Cash Inflow / Outflow of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹-3.38 Cr | Negative | |
| Mar2024 | ₹4.74 Cr | Positive | |
| Mar2023 | ₹-0.64 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,192.5 Cr | 22.8% | 50.9% | 44.5% | Stock Analytics | |
| SAGILITY | ₹19,376.0 Cr | -0.1% | -1.7% | -4.4% | Stock Analytics | |
| PRIME FOCUS | ₹18,755.7 Cr | -4.4% | -24.1% | 139.4% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹18,574.8 Cr | -2.2% | 5.1% | -26.8% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,961.8 Cr | -1.6% | 3.7% | 2.5% | Stock Analytics | |
| INDEGENE | ₹12,526.9 Cr | 2.2% | 4.5% | -14.6% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 22.8% |
50.9% |
44.5% |
| SENSEX | 0.7% |
-1% |
-7% |
You may also like the below Video Courses